home All News open_in_new Full Article

Junshi Biosciences Announces 2025 Interim Financial Results and Provides Corporate Updates

SHANGHAI, Aug. 26, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2025 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of June 30, 2025, the total revenue of Junshi […]


today 2 w. ago attach_file Other

attach_file Culture
attach_file Events
attach_file Other
attach_file Other
attach_file Sport
attach_file Society
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Politics
attach_file Other


ID: 3679034984
Add Watch Country

arrow_drop_down